STYRON™ 2678 MED Polystyrene Resins can be used for a variety of medical device applications including clear packaging, diagnostic components, petri dishes and housings for test kits.
Highlights of the resin material include excellent transparency (approx. 90% transmission), stiffness, rigidity and heat resistance. Properties supporting medical device applications include biocompatibility, sterilization stability, and chemical resistance to fight infection. The material may also be processed further with secondary operations such as solvent bonding, welding and laser marking, typical for medical devices.
“There’s a growing need - especially within medical packaging – for a medical grade polymer that performs well, protects the product, and provides an added degree of safety,” said Ben Porter, technical service & development engineer, Trinseo, Netherlands. “STYRON™ 2678 MED Polystyrene Resin provides customers with an ideal and economical solution and an alternative to general purpose food grade polystyrene.”
Trinseo has served the global medical devices market with high performance plastics for single- and multiple-use devices and equipment housings for nearly three decades. The company offers worldwide production and fulfillment, recently announcing its medical compounding capability in Asia Pacific to complement existing compounding in Europe and North America.
STYRON™ 2678 MED Polystyrene Resin expands Trinseo’s offering of transparent materials for medical applications.
Trinseo (NYSE: TSE) is a global materials solutions provider and manufacturer of plastics, latex binders, and synthetic rubber. We are focused on delivering innovative and sustainable solutions to help our customers create products that touch lives every day — products that are intrinsic to how we live our lives — across a wide range of end-markets, including automotive, appliances, consumer electronics, medical devices, electrical, building and construction, textile, paper and board, footwear and tires. Trinseo had approximately $4.4 billion in net sales in 2017, with 16 manufacturing sites around the world, and approximately 2,200 employees. For more information visit www.trinseo.com
This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. Forward-looking statements in this press release may include, without limitation, forecasts of growth, revenues, business activity, acquisitions, financings and other matters that involve known and unknown risks, uncertainties and other factors that may cause results, levels of activity, performance or achievements to differ materially from results expressed or implied by this press release. As a result of the foregoing considerations, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.